Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-28

FDA Approved: DICYCLOMINE HYDROCHLORIDE — Original Application (Solaris Pharma Corporation)

View source ↗

Summary

FDA approved a generic version of dicyclomine hydrochloride under an Original Application (ANDA) for Solaris Pharma Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dicyclomine hydrochloride (Dicyclomine hydrochloride)

Snippet

ORIG AP for DICYCLOMINE HYDROCHLORIDE (DICYCLOMINE HYDROCHLORIDE)